Latest MGTA reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Magenta Therapeutics logo
Magenta Therapeutics MGTA
$ 0.7 -7.74%

Magenta Therapeutics EBITDA per Share 2011-2024 | MGTA

Annual EBITDA per Share Magenta Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-9.33 -33.9 -1.32 -1.59 -2.19 -3.21 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.32 -33.9 -8.6

Quarterly EBITDA per Share Magenta Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-0.69 - -4.03 - -8.77 - -9.43 -0.31 -0.4 - -0.29 -0.33 -0.38 - -0.35 -0.48 -0.53 -0.63 -0.55 -0.5 -0.48 -0.54 -0.49 -3.12 -4.52 -3.47 -3.37 -9.03 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.29 -9.43 -2.29